Latest neurological disorders Stories

(Ivanhoe Newswire) -- Approximately three out of every 1,000 people in the United States suffer from some degree of Autism. Now, a new study is looking at why this happens by studying your genes. Researchers at UCLA are conducting a study to explain why one person has an ASD (autism spectrum disorder) and another does not. The study pinpoints ASD risk factors by comparing changes in gene expression with DNA mutation data in the same individuals. ASDs are a heterogeneous group of...

Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health. The study, published in the current issue of the journal Brain, is the first to investigate overall cancer risk in MS patients in North America. "Because the immune system plays important roles in both cancer and MS, we wanted to know whether the risk of cancer is different for people with MS," says Elaine...

A pioneering report of genome-wide gene expression in autism spectrum disorders (ASDs) finds genetic changes that help explain why one person has an ASD and another does not. The study, published by Cell Press on June 21 in The American Journal of Human Genetics, pinpoints ASD risk factors by comparing changes in gene expression with DNA mutation data in the same individuals. This innovative approach is likely to pave the way for future personalized medicine, not just for ASD but also for any...

MOUNTAIN VIEW, Calif., June 21, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present data on LEVADEX® (formerly MAP0004), an orally inhaled investigational drug for the acute treatment of migraine, at the 54th Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, CA, June 21-24, 2012. The Company will present five poster presentations: Acute Inhalation Safety of MAP0004: Studies in Healthy...

(Ivanhoe Newswire) – More than 15,000 Americans have Huntington’s disease, a fatal condition marked by uncontrolled movements and cognitive and psychiatric problems. Currently, there are no available treatments to alter the effects of Huntington’s disease, but a new study brings researchers one step closer to finding one. A new gene-silencing strategy can reverse core symptoms associated with Huntington's disease, according to a preclinical study. The short-term therapy produced...

Single treatment produces long-term improvement in animal models With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's disease, slowing and partially reversing progression of the fatal neurodegenerative disorder in animal models. Researchers suggest the drug therapy, tested in mouse and non-human primate models, could produce sustained...

A new gene-silencing strategy can reverse core symptoms associated with Huntington's disease, according to a preclinical study published by Cell Press in the June 21st issue of the journal Neuron. The short-term therapy produced sustained benefits in both mouse and primate animal models of this neurodegenerative disorder, which currently lacks an effective treatment. "Our approach is feasible for development now into a therapy for Huntington's disease in man," says senior study author Don...

Innovative technique expected to play a critical role in diagnosis and treatment of disease The Mount Sinai Medical Center is the first institution in New York State to use in the clinical setting a newly approved imaging technique to detect Alzheimer's disease (AD) in people who are cognitively impaired. Until now, physicians have been limited in their ability to diagnose AD, guided almost exclusively by a patient's mental and behavioral symptoms and family history. The innovative...

Earlier detection, prompt and appropriate treatment, and prevention can lessen neurological, physical and psychological consequences of severe head trauma in America's soldiers and teen athletes The impact of traumatic injuries to the brain – whether sustained in combat or on the playing fields of America's schools – is a major topic for international migraine specialists the week of June 18 as they gather in Los Angeles for the 54th Annual Scientific Sessions of the American Headache...

Scientists from the University of South Florida and Fudan University in Shanghai found increases in brain volume and improvements on tests of memory and thinking in Chinese seniors who practiced Tai Chi three times a week, reports an article published today in the Journal of Alzheimer's Disease. Findings were based on an 8-month randomized controlled trial comparing those who practiced Tai Chi to a group who received no intervention. The same trial showed increases in brain volume and more...